Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 46
Filtrar
1.
Surg Obes Relat Dis ; 17(2): 308-318, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33189600

RESUMO

BACKGROUND: Bariatric surgery results in rapid weight loss and resolution of many co-morbidities including hypertension. OBJECTIVES: To investigate the association of the 2 most common bariatric surgical procedures, vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (RYGB), with sustained remission from hypertension, and evaluate other independent predictors of sustained remission. SETTING: Privately insured patients with hypertension in the United States undergoing bariatric surgery. METHODS: A cohort of hypertensive bariatric patients was created using detailed inclusion and exclusion criteria. Remission was defined as no refill of antihypertensive medication for 30 days after patients' medication was expected to run out, and recurrence as medication refill after at least 90 days of remission. RESULTS: Of 7006 patients in our cohort, 5874 experienced remission of their hypertension (83.8%). 745 of the 5874 (12.7%) patients later experienced recurrence. The adjusted hazard ratio of remission for VSG compared with RYGB was 1.06 (95% confidence interval [CI]; 1.0, 1.11). The adjusted hazard ratio of recurrence for VSG compared with RYGB was .84 (95% CI; .71, .97). A higher number of medications at the time of surgery was associated with a decreased likelihood of remission and an increased risk of recurrence of hypertension. CONCLUSION: There was no difference in the likelihood of remission of hypertension between VSG and RYGB. The number of medications at the time of surgery was the most important predictor of remission and recurrence of hypertension after surgery.


Assuntos
Cirurgia Bariátrica , Derivação Gástrica , Hipertensão/epidemiologia , Obesidade Mórbida , Redução de Peso/fisiologia , Gastrectomia , Humanos , Obesidade Mórbida/cirurgia , Estados Unidos
2.
Br J Anaesth ; 124(3): 261-270, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31864719

RESUMO

BACKGROUND: The Duke Activity Status Index (DASI) questionnaire might help incorporate self-reported functional capacity into preoperative risk assessment. Nonetheless, prognostically important thresholds in DASI scores remain unclear. We conducted a nested cohort analysis of the Measurement of Exercise Tolerance before Surgery (METS) study to characterise the association of preoperative DASI scores with postoperative death or complications. METHODS: The analysis included 1546 participants (≥40 yr of age) at an elevated cardiac risk who had inpatient noncardiac surgery. The primary outcome was 30-day death or myocardial injury. The secondary outcomes were 30-day death or myocardial infarction, in-hospital moderate-to-severe complications, and 1 yr death or new disability. Multivariable logistic regression modelling was used to characterise the adjusted association of preoperative DASI scores with outcomes. RESULTS: The DASI score had non-linear associations with outcomes. Self-reported functional capacity better than a DASI score of 34 was associated with reduced odds of 30-day death or myocardial injury (odds ratio: 0.97 per 1 point increase above 34; 95% confidence interval [CI]: 0.96-0.99) and 1 yr death or new disability (odds ratio: 0.96 per 1 point increase above 34; 95% CI: 0.92-0.99). Self-reported functional capacity worse than a DASI score of 34 was associated with increased odds of 30-day death or myocardial infarction (odds ratio: 1.05 per 1 point decrease below 34; 95% CI: 1.00-1.09), and moderate-to-severe complications (odds ratio: 1.03 per 1 point decrease below 34; 95% CI: 1.01-1.05). CONCLUSIONS: A DASI score of 34 represents a threshold for identifying patients at risk for myocardial injury, myocardial infarction, moderate-to-severe complications, and new disability.


Assuntos
Tolerância ao Exercício/fisiologia , Indicadores Básicos de Saúde , Cuidados Pré-Operatórios/métodos , Adulto , Idoso , Biomarcadores/sangue , Feminino , Nível de Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/etiologia , Infarto do Miocárdio/mortalidade , Peptídeo Natriurético Encefálico/sangue , Fragmentos de Peptídeos/sangue , Complicações Pós-Operatórias/mortalidade , Prognóstico , Estudos Prospectivos , Medição de Risco , Fatores de Risco , Autorrelato , Inquéritos e Questionários
3.
Diabet Med ; 37(2): 362-368, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31559651

RESUMO

AIM: To compare the characteristics of and outcomes for people with malignancies with and without a co-diagnosis of diabetes. METHODS: Emergency department and hospital discharge data from a single centre for the period between 1 January 2015 and 31 December 2017 were used to identify people with a diagnosis of a malignancy and diabetes. Multivariate Cox regression models were used to estimate the effect of diabetes on all-cause mortality. A truncated negative binomial regression model was used to assess the impact of diabetes on length of hospital inpatient stay. Prentice-Williams-Peterson total time models were used to assess the effect of diabetes on number of emergency department re-presentations and inpatient re-admissions. RESULTS: Of 7004 people identified with malignancies, 1195 (17.1%) were also diagnosed with diabetes. A diagnosis of diabetes was associated with a greater number of inpatient re-admissions [adjusted hazard ratio 1.13 (95% CI 1.03, 1.24)], a greater number of emergency department re-presentations [adjusted hazard ratio 1.13 (95% CI 1.05, 1.22)] and longer length of stay [adjusted incidence rate ratio 1.14 (95% CI 1.04, 1.25)]. A co-diagnosis of diabetes was also associated with a 48% increased risk of all-cause mortality [adjusted hazard ratio 1.48 (95% CI 1.22-1.76)]. CONCLUSIONS: People with malignancies and diabetes had significantly more emergency department presentations, more inpatient admissions, longer length of hospital stay and higher rates of all-cause mortality compared to people with a malignancy without diabetes.


Assuntos
Diabetes Mellitus Tipo 2/epidemiologia , Serviço Hospitalar de Emergência/estatística & dados numéricos , Hospitalização/estatística & dados numéricos , Tempo de Internação/estatística & dados numéricos , Mortalidade , Neoplasias/epidemiologia , Idoso , Idoso de 80 Anos ou mais , Austrália/epidemiologia , Estudos de Casos e Controles , Causas de Morte , Estudos de Coortes , Comorbidade , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Modelos de Riscos Proporcionais , Estudos Retrospectivos
4.
Clin Obes ; 8(5): 345-354, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30107093

RESUMO

Bariatric surgery is a safe and effective intervention to treat severe obesity and related comorbidities in adolescents. No qualitative studies have explored the perspectives of US adolescent weight-loss patients on their bariatric surgery motivations, decision-making or experiences. The purpose of this qualitative exploratory study was to explore the perspectives of adolescent patients seeking bariatric surgery while enrolled in a medical weight management programme. Eligible participants 13-21 years old were recruited through a weight management programme at a tertiary care children's hospital in the US Midwest. Interviews were conducted remotely using a video chat medium. An initial 60-min semi-structured interview was conducted with seven participants who were 16-21 years old: one deciding on bariatric surgery, one pre-operative and five post-operative. A brief follow-up interview was conducted 1 month later with four participants. Interviews were transcribed and coded using Atlas.ti software. Three broad themes emerged from participants' reflections: the long journey to surgery, time scarcity and be ready for change. The decision to pursue bariatric surgery takes place after struggling with obesity and failed weight-loss attempts since early childhood. Post-operative participants described bariatric surgery as life-changing, but determining when to schedule surgery is a challenge for adolescents.


Assuntos
Obesidade Mórbida/cirurgia , Obesidade Infantil/cirurgia , Pesquisa Qualitativa , Adolescente , Saúde do Adolescente , Adulto , Cirurgia Bariátrica , Feminino , Seguimentos , Humanos , Masculino , Obesidade Mórbida/psicologia , Período Pós-Operatório , Estados Unidos , Adulto Jovem
5.
Obes Sci Pract ; 1(2): 88-96, 2015 12.
Artigo em Inglês | MEDLINE | ID: mdl-27774252

RESUMO

OBJECTIVE: To investigate the association between adverse surgical outcomes following bariatric surgery and proxy measures of vitamin D (VitD) status (season and latitude) in the Nationwide Inpatient Sample (NIS). BACKGROUND: Obesity is an independent risk factor for VitD deficiency (25(OH)D < 20 ng ml-1). VitD deficiency compounds the chronic inflammation of obesity, increasing the risk of adverse outcomes following bariatric surgery. Epidemiology has long used season and latitude as proxies for group VitD, as VitD status is largely determined by sun exposure, which is greatest during summer and at the Equator. METHODS: We assessed proxy measures of group VitD status. We compared surgeries in VitD Summer (July to September), Winter (January to March), and Fall/Spring (October to December and April to June) and in the North (≥37°N) vs. the South (<37°N). RESULTS: We identified 932,091 bariatric surgeries; 81.2% were women and 74.4% were white. Sex was unequally distributed by season (p = 0.005). Median age was 43.0 years (all groups). Most surgeries occurred in the North (64.8%). Adverse outcome rates ranged from 0.01% (wound infections) to 39.4% [prolonged length of stay {LOS}]. Season was inversely associated with wound infection (p = 0.018) and dehiscence (p = 0.001). Extended LOS was inversely correlated with season (p < 0.001). These relationships held after adjustment. Prolonged LOS (p < 0.001) and any complication (p = 0.108) were more common in the North. CONCLUSIONS: We have demonstrated a graded relationship between seasonality and adverse outcomes following bariatric surgery. The association was strongest for dehiscence and prolonged LOS. These relationships held when using latitude. A prospective study measuring pre-operative 25(OH)D concentration would strengthen the case for causality in adverse surgical outcomes.

6.
Obes Sci Pract ; 1(2): 104-109, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27774253

RESUMO

BACKGROUND: Meal tolerance tests are frequently used to study dynamic incretin and insulin responses in the postprandial state; however, the optimal meal that is best tolerated and suited for hormonal response following surgical and medical weight loss has yet to be determined. OBJECTIVE: To evaluate the tolerability and effectiveness of different test meals in inducing detectable changes in markers of glucose metabolism in individuals who have undergone a weight loss intervention. METHODS: Six individuals who underwent surgical or medical weight loss (two Roux-en-Y gastric bypass, two sleeve gastrectomy and two medical weight loss) each completed three meal tolerance tests using liquid-mixed, solid-mixed and high-fat test meals. The tolerability of each test meal, as determined by the total amount consumed and palatability, as well as fasting and meal-stimulated glucagon-like peptide, glucose-dependent insulinotropic polypeptide, insulin and glucose were measured. RESULTS: Among the six individuals, the liquid-mixed meal was better and more uniformly tolerated with a median meal completion rate of 99%. Among the four bariatric surgical patients, liquid-mixed meal stimulated on average a higher glucagon-like peptide (percent difference: 83.7, 89), insulin secretion (percent difference: 155.1, 158.7) and glucose-dependent insulinotropic polypeptide (percent difference: 113.5, 34.3) compared with solid-mixed and high-fat meals. CONCLUSIONS: The liquid-mixed meal was better tolerated with higher incretin and insulin response compared with the high-fat and solid-mixed meals and is best suited for the evaluation of stimulated glucose homeostasis.

7.
J Hand Surg Eur Vol ; 38(9): 992-9, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23348603

RESUMO

The wide-awake hand surgery (WAHS) technique involves injecting lidocaine with adrenaline for hand surgical procedures that are done without the use of tourniquets, sedation, regional or general anaesthetic. This is a retrospective review of the first 100 consecutive patients who underwent operations using this technique at our centre. The operations included carpal and cubital tunnel decompression, trapeziectomy, tendon transfer, and tenolysis. A questionnaire adapted from Lalonde's previous work on wide-awake surgery was used to assess patients' experiences. Sixty-five percent of the patients responded to the postal questionnaire, the majority reporting a high satisfaction level. Ninety-one percent of responders reported that the operation was less painful or comparable with a procedure at the dentist; 86% would prefer to be wide-awake if they needed to have hand surgery again, and 90% stated they would recommend WAHS to a friend.


Assuntos
Anestésicos Locais/administração & dosagem , Estado de Consciência , Mãos/cirurgia , Satisfação do Paciente , Adulto , Idoso , Idoso de 80 Anos ou mais , Ansiedade/psicologia , Epinefrina/administração & dosagem , Feminino , Humanos , Injeções , Lidocaína/administração & dosagem , Masculino , Pessoa de Meia-Idade , Procedimentos Ortopédicos , Medição da Dor , Preferência do Paciente , Estudos Retrospectivos , Inquéritos e Questionários , Vasoconstritores/administração & dosagem , Adulto Jovem
10.
Surg Endosc ; 22(9): 2056-61, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18270773

RESUMO

BACKGROUND: Laparoscopic Roux-en-Y gastric bypass surgery reportedly has a higher rate of postoperative internal hernias than open bypass surgery. Even with closure of mesenteric defects, hernias occur in up to 9% of cases. To minimize this complication, an antecolic antegastric approach to anastomosis of the Roux limb and gastric pouch has been used. Whereas the retrocolic retrogastric technique creates three mesenteric defects, the antecolic approach produces only two: Petersen's defect and the jejunojejunostomy. The rate of internal hernias was compared among patients undergoing laparoscopic Roux-en-Y gastric bypass surgery using the retrocolic and antecolic approaches. METHODS: The experience of a single surgeon from August 2001 to September 2005 was reviewed. Only Roux-en-Y gastric bypass procedures were included. Patients were followed for a minimum of 18 months postoperatively. The retrocolic approach was used for 274 patients and the antecolic approach for 205 patients. All defects were closed at the time of surgery. With the antecolic approach, Petersen's defect was closed from the root of the mesentery of the Roux limb and the transverse colon mesentery up to the transverse colon. RESULTS: Of the 274 patients, 7 (2.6%) experienced a symptomatic internal hernia with the retrocolic retrogastric technique. No internal hernias were reported among the 205 patients treated with the antecolic antegastric method. Chi-square analysis showed that an antecolic approach was associated with a decreased rate of internal hernias (p < 0.025). Of 479 patients, 35 (7%) underwent diagnostic laparoscopy without any internal hernia found. Of these patients, 15 were found to have cholelithiasis and subjected to laparoscopic cholecystectomy. CONCLUSIONS: The antecolic antegastric approach to laparoscopic Roux-en-Y gastric bypass is associated with fewer postoperative hernias than the retrocolic retrogastric approach. The frequency of hernias using either technique is low if meticulous attention is paid to closure of all mesenteric defects.


Assuntos
Derivação Gástrica/métodos , Hérnia Ventral/prevenção & controle , Laparoscopia/métodos , Complicações Pós-Operatórias/prevenção & controle , Colecistectomia Laparoscópica/métodos , Colelitíase/complicações , Colelitíase/cirurgia , Hérnia Ventral/etiologia , Humanos , Procedimentos Cirúrgicos Minimamente Invasivos/métodos , Obesidade Mórbida/complicações , Obesidade Mórbida/cirurgia , Complicações Pós-Operatórias/etiologia , Estudos Retrospectivos
11.
Palliat Med ; 18(8): 692-7, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15623165

RESUMO

One of the major reasons for admission of patients to hospital in late stage disease is the inability of carers to continue to provide care at home. Specialist palliative care services have typically admitted patients for acute symptom control, terminal care and respite care to benefit them and their carers. This paper reports the results of a cross-sectional survey of inpatient respite care provision provided by specialist palliative care services and hospices in the UK. A structured questionnaire was mailed to 242 clinical services managers listed in the Hospice Information Directory in 2003. A 69% response rate was achieved. The questionnaire explored the nature of respite services, their purpose, organization, delivery and examined definitions used. The analysis indicated that 80% of the sample provided inpatient respite care. Most inpatient respite admissions were planned, of fixed duration (7-14 days) and were intended to benefit patients and carers. There was some evidence that respite provision was regarded as a lower priority than admissions for symptom control and terminal care, and that patients' needs were prioritized over those of carers. Only 10% of services conducted regular, routine audit, with very few seeking the views of service users. Findings suggest that carers' needs and wishes are not prioritized by specialist palliative care services offering inpatient respite, which may mean that they find it difficult to maintain their caregiving roles over longer disease trajectories or in the face of overwhelming demands.


Assuntos
Cuidadores/psicologia , Cuidados Paliativos/métodos , Estudos Transversais , Atenção à Saúde/métodos , Humanos , Cuidados Intermitentes/métodos , Cuidados Intermitentes/provisão & distribuição , Inquéritos e Questionários , Reino Unido
12.
J Clin Pathol ; 56(3): 233-6, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12610106

RESUMO

This report describes two patients who developed leiomyosarcomas, one involving the subcutaneous tissue of the thigh and the pelvic soft tissues and the other the urinary bladder, following hereditary retinoblastoma 36 and 38 years earlier, respectively. There is an increased risk of the development of sarcoma, most commonly osteosarcoma, as a second malignancy following hereditary retinoblastoma. Leiomyosarcoma developing as a second malignancy has rarely been reported and most have occurred in the field of previous radiotherapy. The literature on leiomyosarcoma occurring as a second neoplasm following retinoblastoma is reviewed.


Assuntos
Leiomiossarcoma/patologia , Segunda Neoplasia Primária/patologia , Retinoblastoma/radioterapia , Neoplasias de Tecidos Moles/patologia , Neoplasias da Bexiga Urinária/patologia , Adulto , Feminino , Humanos , Masculino , Neoplasias Induzidas por Radiação/patologia , Retinoblastoma/genética , Neoplasias Retroperitoneais/patologia
13.
J Med Primatol ; 31(2): 84-90, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12110051

RESUMO

Spontaneous amyloidosis occurs in many nonhuman primate species but remains difficult to diagnose and treat. Nonhuman primates continue to offer promise as animal models in which to study amyloidosis in humans. Amyloidosis was not diagnosed clinically but was found histologically in four male and 36 female baboons. The baboons averaged 18 years of age at death (range, 7-28 years). Clinical signs, if present, were hyperglycemia and cachexia. Blood glucose values were elevated in 12 of 30 baboons with available clinical pathology data. Four baboons had been clinically diagnosed as diabetic and three were treated with insulin. Amyloid was found in the islets of Langerhans of the pancreas in 40 baboons; 35 baboons had amyloid only in the islets of Langerhans. Amyloid was found in nonislet tissue of baboons as follows: five, nonislet pancreas; four, intestine and adrenal; three, kidney; two, prostate and spleen; and one each, lymph node, liver, gall bladder, stomach, tongue, urinary bladder, and salivary gland. Sections of paraffin-embedded tissues were evaluated for amyloid with hematoxylin and eosin (HE) and congo red (CR) staining, and using immunohistochemistry for human islet amyloid polypeptide (IAPP), calcitonin gene-related peptide (CGRP), glucagon, pancreatic polypeptide (PP), somatostatin (SS), and porcine insulin. Islet amyloid was positive with HE in 40 baboons, with CR in 39 baboons, and with IAPP and CGRP in 35 baboons. IAPP and CGRP only stained islet amyloid. PP, SS, glucagon, and porcine insulin did not stain amyloid. Islet amyloidosis in the baboon appears to be difficult to diagnose clinically, age-related, and similar to islet amyloidosis in other species. The baboon may be a good model for the study of islet amyloidosis in humans.


Assuntos
Amiloide/análise , Amiloidose/veterinária , Ilhotas Pancreáticas/patologia , Papio , Amiloidose/diagnóstico , Amiloidose/patologia , Animais , Glicemia/análise , Diabetes Mellitus/veterinária , Modelos Animais de Doenças , Feminino , Imuno-Histoquímica , Masculino
14.
J Comp Pathol ; 126(1): 76-8, 2002 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11814325

RESUMO

An adult pygmy African hedgehog developed acute posterior paresis attributed to a prolapsed intervertebral disc diagnosed by C-T scan. Corticosteroid therapy resulted in prompt resolution of the ataxia, but 2 weeks later the animal became anorexic and died. Macroscopically, the liver was stippled with punctate off-white foci which were confirmed microscopically to be foci of necrosis. Numerous hepatocytes contained intranuclear inclusions and syncytial cell formation was also present. A herpes virus was isolated and identified by fluorescent antibody and polymerase chain reaction studies as herpesvirus simplex type 1. To our knowledge, this is the first report of herpes infection in the African hedgehog and the first time herpes simplex has been identified as a cause of disease in insectivores.


Assuntos
Animais de Zoológico , Ouriços , Herpes Simples/veterinária , Simplexvirus/isolamento & purificação , Animais , Antígenos Virais/análise , DNA Viral/análise , Evolução Fatal , Feminino , Técnica Direta de Fluorescência para Anticorpo , Herpes Simples/patologia , Técnicas Imunoenzimáticas , Corpos de Inclusão/ultraestrutura , Fígado/patologia , Fígado/virologia , Paresia/etiologia , Paresia/patologia , Paresia/veterinária , Reação em Cadeia da Polimerase , Simplexvirus/genética , Simplexvirus/imunologia , Tálamo/patologia , Tálamo/virologia
15.
Cochrane Database Syst Rev ; (1): CD002734, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11279764

RESUMO

BACKGROUND: Bronchiectasis is characterised by chronic sputum production,bronchial wall dilation,recurrent infection and airflow limitation. Methylxanthines are used in the management of airflow limitation associated with asthma and COPD, where they are also purported to have anti-inflammatory properties. In theory they may be of use in bronchiectasis. OBJECTIVES: To determine the efficacy of methylxanthines in the treatment of bronchiectasis. SEARCH STRATEGY: The Cochrane Airways Group clinical trials register derived from MEDLINE,EMBASE and hand searches using the terms bronchiectasis, aminophylline, theophylline and methyl- xanthine SELECTION CRITERIA: Only randomised controlled trials were to be considered. DATA COLLECTION AND ANALYSIS: The results of the searches were reviewed by two authors. Searches yielded seven trials none of which met the inclusion criteria. MAIN RESULTS: No randomised controlled trials were identified. REVIEWER'S CONCLUSIONS: Further research is required to establish if the methylxanthines have a role in the treatment of bronchiectasis.


Assuntos
Aminofilina/administração & dosagem , Bronquiectasia/tratamento farmacológico , Broncodilatadores/administração & dosagem , Teofilina/administração & dosagem , Administração Oral , Humanos , Ensaios Clínicos Controlados Aleatórios como Assunto
16.
Arch Pathol Lab Med ; 125(5): 625-30, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11300932

RESUMO

BACKGROUND: In vitro studies have previously shown that Ebola virus glycoprotein (GP) is rapidly processed and largely released from infected cells, whereas other viral proteins, such as VP40, accumulate within cells. OBJECTIVE: To determine infected cell types in which Ebola virus GP and VP40, individually, localize in vivo. METHODS: Immunohistochemistry and in situ hybridization using GP- and VP40-specific antibodies and genetic probes were used to analyze archived tissues of experimentally infected nonhuman primates and guinea pigs and Vero E6 and 293 cells infected in vitro. RESULTS: The GP antigen was consistently present in hepatocytes, adrenal cortical cells, fibroblasts, fibroblastic reticular cells, ovarian thecal cells, and several types of epithelial cells, but was not detected in macrophages and blood monocytes of animals, nor in Vero cells and 293 cells. All GP-positive and GP-negative cell types analyzed contained VP40 antigen and both GP and VP40 RNAs. CONCLUSIONS: Ebola virus GP appears to selectively accumulate in many cell types infected in vivo, but not in macrophages and monocytes. This finding suggests that many cell types may have a GP-processing pathway that differs from the pathway described by previous in vitro studies. Differential cellular localization of GP could be relevant to the pathogenesis of Ebola hemorrhagic fever.


Assuntos
Doença pelo Vírus Ebola/virologia , Glicoproteínas de Membrana/análise , Proteínas da Matriz Viral/análise , Animais , Linhagem Celular , Chlorocebus aethiops , Cobaias , Hibridização In Situ , Macaca mulatta , Macrófagos/virologia , Glicoproteínas de Membrana/biossíntese , Glicoproteínas de Membrana/genética , Monócitos/virologia , Nucleoproteínas/análise , Nucleoproteínas/biossíntese , Nucleoproteínas/genética , RNA Mensageiro/biossíntese , Distribuição Tecidual , Células Vero , Proteínas do Core Viral/análise , Proteínas do Core Viral/biossíntese , Proteínas do Core Viral/genética , Proteínas da Matriz Viral/biossíntese , Proteínas da Matriz Viral/genética
17.
J Comp Pathol ; 125(4): 233-42, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11798240

RESUMO

Guinea-pigs and non-human primates have traditionally been used as animal models for studying Ebola Zaire virus (EBO-Z) infections. The virus was also recently adapted to the stage of lethal virulence in BALB/c mice. This murine model is now in use for testing antiviral medications and vaccines. However, the pathological features of EBO-Z infection in mice have not yet been fully described. To identify sites of viral replication and characterize sequential morphological changes in BALB/c mice, adult female mice were infected with mouse-adapted EBO-Z and killed in groups each day for 5 days post-infection. Tissues were examined by light microscopy, immunohistochemistry, electron microscopy and in-situ hybridization. As in guinea-pigs and non-human primates, cells of the mononuclear phagocytic system were the earliest targets of infection. Viral replication was observed by day 2 in macrophages in lymph nodes and spleen. By the time of onset of illness and weight loss (day 3), the infection had spread to hepatocytes and adrenal cortical cells, and to macrophages and fibroblast-like cells in many organs. Severe lymphocytolysis was observed in the spleen, lymph nodes and thymus. There was minimal infection of endothelial cells. All of these changes resembled those observed in EBO-Z-infected guinea-pigs and non-human primates. In contrast to the other animal models, however, there was little fibrin deposition in the late stage of disease. The availability of immunodeficient, "gene-knockout" and transgenic mice will make the mouse model particularly useful for studying the early steps of Ebola pathogenesis.


Assuntos
Ebolavirus/patogenicidade , Doença pelo Vírus Ebola/virologia , Animais , Anticorpos Monoclonais/imunologia , Antígenos Virais/análise , Modelos Animais de Doenças , Ebolavirus/genética , Ebolavirus/imunologia , Feminino , Doença pelo Vírus Ebola/patologia , Técnicas Imunoenzimáticas , Hibridização In Situ , Corpos de Inclusão Viral/ultraestrutura , Tecido Linfoide/patologia , Tecido Linfoide/virologia , Camundongos , Camundongos Endogâmicos BALB C , Microscopia Eletrônica , RNA Viral/análise , Proteínas do Envelope Viral/análise , Replicação Viral
18.
J Med Primatol ; 30(5): 260-7, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11990241

RESUMO

Spontaneous amyloidosis was diagnosed in 11 male and 1 female chimpanzees and confirmed histologically and immunohistochemically. The chimpanzees were > or = 15 years of age when first diagnosed and averaged 22.4 years of age. The average survival time after diagnosis of systemic amyloidosis was 1.86 years with a standard deviation of 4.06 years (n = 7). The chimpanzees with amyloidosis were asymptomatic except for hepatomegaly, which became more detectable with age. Significant increases in clinical chemistry values, as compared with referenced normals and established normals, of blood urea nitrogen (BUN), asparate aminotransferase (AST), gamma-glutamyltransferase (GGT), globulin, total protein, creatinine phosphokinase (CPK), sedimentation rate, and triglycerides were found in animals 7 years of age or older with amyloidosis. These serum chemistry values, while increased in chimpanzees with amyloidosis, were generally within normal limits. Immunohistochemistry for both amyloid A protein and amyloid P component-labeled extracellular amyloid in all chimpanzees with amyloidosis was determined. Amyloid was deposited primarily in the liver. Amyloidosis in the chimpanzee is a chronic, intractable, progressive, fatal disease, and appears to be similar to secondary amy loidosis in other species.


Assuntos
Amiloidose/veterinária , Doenças dos Símios Antropoides/patologia , Pan troglodytes , Amiloidose/sangue , Amiloidose/metabolismo , Amiloidose/patologia , Animais , Doenças dos Símios Antropoides/sangue , Doenças dos Símios Antropoides/metabolismo , Biópsia/veterinária , Análise Química do Sangue/veterinária , Feminino , Hepatomegalia/metabolismo , Hepatomegalia/patologia , Imuno-Histoquímica/veterinária , Fígado/patologia , Masculino , Proteína Amiloide A Sérica/análise , Componente Amiloide P Sérico/análise
19.
Comp Med ; 50(1): 59-68, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10987671

RESUMO

BACKGROUND AND PURPOSE: Callitrichids (marmosets and tamarins) are extremely susceptible to experimental tumor induction by herpesviruses native to other primate species. A colony of common marmosets developed a syndrome of weight loss, inappetence, diarrhea, and in several animals, palpable abdominal masses. METHODS: Marmosets in the colony were subjected to histologic examination and serologic testing for Epstein-Barr virus (EBV). The DNA from tumors that developed in the marmosets was subjected to consensus primer polymerase chain reaction (PCR) analysis designed to amplify conserved regions of herpesvirus genomes. RESULTS: The mesenteric lymph nodes and intestinal mucosa were consistently infiltrated by principally B lymphocytes, which often obliterated the normal architecture. Of 84 clinically normal marmosets, 52 were seropositive for EBV. The tumor DNA contained previously unreported herpesvirus sequences closely related to but distinct from those of EBV, Herpesvirus papio, and these lymphocryptovirus, a novel gammaherpesvirus. Results of PCR analysis of circulating lymphocytes from EBV-positive, clinically normal marmosets were negative for EBV antibodies and were positive for marmoset lymphocryptovirus; PCR analysis of circulating lymphocytes from EBV-negative marmosets yielded negative results for EBV and this novel marmoset lymphocryptovirus. CONCLUSION: This novel gammaherpesvirus possibly associated with tumor development may have important management implications for captive callitrichids.


Assuntos
Callithrix/virologia , Gammaherpesvirinae/classificação , Infecções por Herpesviridae/veterinária , Transtornos Linfoproliferativos/veterinária , Doenças dos Macacos/virologia , Infecções Tumorais por Vírus/veterinária , Sequência de Aminoácidos , Animais , Anticorpos Antivirais/sangue , Sequência de Bases , Primers do DNA/química , DNA Viral/química , DNA Viral/isolamento & purificação , Surtos de Doenças/veterinária , Reservatórios de Doenças/veterinária , Feminino , Técnica Indireta de Fluorescência para Anticorpo/veterinária , Gammaherpesvirinae/química , Gammaherpesvirinae/genética , Infecções por Herpesviridae/epidemiologia , Infecções por Herpesviridae/virologia , Imuno-Histoquímica , Mucosa Intestinal/patologia , Mucosa Intestinal/virologia , Linfonodos/patologia , Linfonodos/virologia , Transtornos Linfoproliferativos/epidemiologia , Transtornos Linfoproliferativos/virologia , Masculino , Dados de Sequência Molecular , Doenças dos Macacos/epidemiologia , Filogenia , Reação em Cadeia da Polimerase/veterinária , Análise de Sequência de DNA , Estudos Soroepidemiológicos , Infecções Tumorais por Vírus/epidemiologia , Infecções Tumorais por Vírus/virologia , Wisconsin/epidemiologia
20.
Science ; 286(5448): 2333-7, 1999 Dec 17.
Artigo em Inglês | MEDLINE | ID: mdl-10600742

RESUMO

In late summer 1999, an outbreak of human encephalitis occurred in the northeastern United States that was concurrent with extensive mortality in crows (Corvus species) as well as the deaths of several exotic birds at a zoological park in the same area. Complete genome sequencing of a flavivirus isolated from the brain of a dead Chilean flamingo (Phoenicopterus chilensis), together with partial sequence analysis of envelope glycoprotein (E-glycoprotein) genes amplified from several other species including mosquitoes and two fatal human cases, revealed that West Nile (WN) virus circulated in natural transmission cycles and was responsible for the human disease. Antigenic mapping with E-glycoprotein-specific monoclonal antibodies and E-glycoprotein phylogenetic analysis confirmed these viruses as WN. This North American WN virus was most closely related to a WN virus isolated from a dead goose in Israel in 1998.


Assuntos
Surtos de Doenças , Febre do Nilo Ocidental/epidemiologia , Febre do Nilo Ocidental/virologia , Vírus do Nilo Ocidental/classificação , Vírus do Nilo Ocidental/genética , Sequência de Aminoácidos , Animais , Anticorpos Monoclonais/imunologia , Anticorpos Antivirais/imunologia , Sequência de Bases , Doenças das Aves/epidemiologia , Doenças das Aves/virologia , Aves/virologia , Vírus da Encefalite Japonesa (Subgrupo)/classificação , Vírus da Encefalite Japonesa (Subgrupo)/genética , Técnica Indireta de Fluorescência para Anticorpo , Genoma Viral , Humanos , Dados de Sequência Molecular , New England/epidemiologia , Cidade de Nova Iorque/epidemiologia , Filogenia , Aves Canoras/virologia , Proteínas do Envelope Viral/química , Proteínas do Envelope Viral/genética , Proteínas do Envelope Viral/imunologia , Febre do Nilo Ocidental/veterinária , Vírus do Nilo Ocidental/imunologia , Vírus do Nilo Ocidental/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA